ARQT
Arcutis Biotherapeutics, Inc. Common Stock ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
Arcutis Biotherapeutics, Inc. Common Stock (ARQT) is held by 4 tracked hedge fund(s). Largest tracked holder: Suvretta Capital.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Suvretta Capital Aaron Cowen |
7.4% | 12.3M | $290M | ▲ 3.0% (+363K) | $9.34 | 2026-03-31 |
| Rubric Capital Management LP Rubric Capital Management LP |
2.1% | 8.3M | $195M | — | $8.97 | 2026-03-31 |
| Polar Capital Holdings Plc Polar Capital Holdings Plc |
0.5% | 5.7M | $134M | ▲ 2.0% (+111K) | $9.61 | 2026-03-31 |
| GILDER GAGNON HOWE & CO LLC GILDER GAGNON HOWE & CO LLC |
1.2% | 4.3M | $101M | ▼ 3.4% (−150K) | $11.18 | 2026-03-31 |
FAQ ▾
Which hedge funds hold ARQT?
Tracked holders include: Suvretta Capital, Rubric Capital Management LP, Polar Capital Holdings Plc, GILDER GAGNON HOWE & CO LLC.
How much smart money owns ARQT?
4 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading ARQT?
No tracked Congressional trades in ARQT on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.